Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapyFabrice Viol(Universität Hamburg), Jörg Schrader(Universität Hamburg)Cellular OncologyOctober 21, 202210.1007/s13402-022-00727-zCited by 19SaveCiteExport RISWatch citationsRelated PapersMatrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells|Hepatology|2010|732